Ferronova Transforming Cancer Outcomes
  • Home
  • About Us
    • About Ferronova
    • Leadership
    • Scientific Advisory
  • The Technology
  • Trials
  • News & Events
    • News
    • Key Conferences
  • Contact Us
Select Page

Fast-tracked: First in-human trial for aggressive brain tumours

by Sarah No | May 12, 2022 | Uncategorized

A novel technology designed to precisely image aggressive brain cancers and guide treatment is being developed by the University of South Australia and Australian cancer diagnostic company, Ferronova, potentially helping thousands of people who are diagnosed with the...

Ferronova secures $826,000 BioMedTech Horizons Grant Funding

by admin | Jul 20, 2020 | Uncategorized

Australian biotechnology company Ferronova Pty Ltd today announced it had been awarded an $826,000 grant from the Australian Government’s BioMedTech Horizons (BTMH) program, operated by MTPConnect to further its nanoparticle development program. Ferronova Chief...

Ferronova secures $3.5m Series A funding led by Uniseed

by Sarah No | May 26, 2020 | Uncategorized

Ferronova, the Australian company developing a technology to help speed up the early detection of the spread of cancer received $3.5 million in funding as it plans human trials for oral, breast and colorectal cancers. The technology – a hybrid smart magnetic and...

Ferronova cancer tracers ready for human trials

by Sarah No | Oct 30, 2019 | Uncategorized

An Adelaide company’s SA-made tiny cancer tracers are ready to be put to the test in first human trials on patients at the Royal Adelaide Hospital.   Read...

UniSA cancer detection technology spin-out Ferronova brings in Signostics co-founder Stewart Bartlett as chief executive

by Sarah No | Nov 13, 2017 | Uncategorized

THE co-founder of an Adelaide medical devices company that eventually attracted millions from global equity giant KKR is now helping another start-up to raise money for its first human trials next year.   Read...

Ferronova’s magnet cancer detection device draws investors

by Sarah No | Jun 20, 2016 | Uncategorized

A NEW spin-out company will receive funding support from international partners to commercialise a locally-developed medical device that helps in easier detection of cancers using magnetic tracers. Ferronova has spun-out of research done at University of South...
« Older Entries

Recent Posts

  • Fast-tracked: First in-human trial for aggressive brain tumours
  • Joint Annual Meeting ISMRM-ESMRMB & SMRT 31st Annual Meeting
  • ASCRS Annual Scientific Meeting
  • AHNS Annual Meeting
  • ASCO Conference

Recent Comments

    Contact | About Us | Privacy

    Copyright © 2021 Ferronova | Ferronova, MM3-02, MM Building, UniSA, Mawsons Lakes Blvd, Mawson Lakes SA 5095, Australia

    Caution: Ferronova products are undergoing clinical trials and are not approved for commercial use.

    V3.0. 12.8.22 

    • Follow
    • Follow
    .
    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT